Mariners' Bryce Miller Expected to Avoid Elbow Surgery After Injury-Shortened Season

Seattle Mariners pitcher Bryce Miller faced a challenging 2025 season due to a bone spur in his right elbow, which led to multiple stints on the injured list and a significant increase in his ERA from 2.94 in 2024 to 5.68 this year. Despite these struggles, Miller showed improvement late in the season and performed well in the playoffs, posting a 1.88 ERA across three starts and expressing optimism about his health and readiness for 2026. He received a platelet-rich plasma injection in June and is expected to avoid surgery, with upcoming follow-up appointments planned to determine further treatment, likely involving cortisone injections during the offseason and spring training. The Mariners remain hopeful that Miller can return to his 2024 form, as his recent postseason performance was a positive sign for the franchise. His ability to recover and maintain health will be critical as Seattle looks to strengthen its rotation moving forward. Overall, Miller's outlook is cautiously optimistic, with medical staff and the player focusing on non-invasive treatments to manage his elbow condition.